Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Incyte Corp (INCY)  
$62.11 0.58 (0.93%) as of 4:30 Fri 6/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 219,000,000
Market Cap: 13.60(B)
Last Volume: 4,892,041 Avg Vol: 1,656,287
52 Week Range: $51.18 - $66.59
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  144
Guru Rank Value     : 7.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,093 9,115 40,352 139,368
Total Sell Value $64,389 $589,575 $2,579,669 $10,851,936
Total People Sold 1 3 4 7
Total Sell Transactions 1 3 7 16
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 1564
  Page 3 of 63  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Cagnoni Pablo J President, R&D   •       –      –    2023-07-14 4 A $0.00 $0 D/D 9,668 202,068     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2023-07-14 4 A $0.00 $0 D/D 13,535 119,094     -
   Flannelly Barry P EVP & General Manager US   •       –      –    2023-07-14 4 A $0.00 $0 D/D 9,668 81,378     -
   Tray Thomas Principal Accounting Officer   •       –      –    2023-07-14 4 A $0.00 $0 D/D 6,015 24,539     -
   Stamoulis Christiana EVP & Chief Financial Officer   •       –      –    2023-07-14 4 A $0.00 $0 D/D 12,246 82,993     -
   Dhanak Dashyant EVP & Chief Scientific Officer   •       –      –    2023-07-14 4 A $0.00 $0 D/D 8,056 58,968     -
   Pasquale Maria E EVP & General Counsel   •       –      –    2023-07-14 4 A $0.00 $0 D/D 9,668 69,724     -
   Hoppenot Herve Chairman / CEOPresident   •       •      –    2023-07-14 4 A $0.00 $0 D/D 43,184 434,856     -
   Iyengar Vijay K EVP, GMAPPS   •       –      –    2023-07-14 4 A $0.00 $0 D/D 7,089 44,069     -
   Pasquale Maria E EVP & General Counsel   •       –      –    2023-07-03 4 D $62.08 $525,693 D/D (8,468) 60,056     -
   Dhanak Dashyant EVP & Chief Scientific Officer   •       –      –    2023-07-03 4 D $62.08 $375,212 D/D (6,044) 50,912     -
   Swain Paula J EVP, Human Resources   •       –      –    2023-07-03 4 D $62.08 $359,009 D/D (5,783) 78,890     -
   Iyengar Vijay K EVP, GMAPPS   •       –      –    2023-07-03 4 D $62.08 $385,827 D/D (6,215) 36,980     -
   Stein Steven H EVP & Chief Medical Officer   •       –      –    2023-07-03 4 D $62.08 $524,079 D/D (8,442) 105,559     -
   Hoppenot Herve Chairman / CEOPresident   •       •      –    2023-07-03 4 D $62.08 $2,698,431 D/D (43,467) 391,672     -
   Tray Thomas Principal Accounting Officer   •       –      –    2023-07-03 4 D $62.08 $70,523 D/D (1,136) 18,524     -
   Stamoulis Christiana EVP & Chief Financial Officer   •       –      –    2023-07-03 4 D $62.08 $377,012 D/D (6,073) 70,747     -
   Flannelly Barry P EVP & General Manager US   •       –      –    2023-07-03 4 D $62.08 $391,352 D/D (6,304) 71,710     -
   Clancy Paul J Director   –       •      –    2023-06-30 4 A $62.25 $23,655 D/D 380 14,591     -
   Baker Felix Director   –       •       •   2023-06-30 4 A $0.00 $0 I/I 1,024 33,446,372     -
   Harrigan Edmund Director   –       •      –    2023-06-30 4 A $62.25 $24,278 D/D 390 11,890     -
   Schaffert Susanne Director   –       •      –    2023-06-14 4 D $61.44 $29,983 D/D (488) 3,642     -
   Schaffert Susanne Director   –       •      –    2023-06-14 4 A $0.00 $0 D/D 2,505 4,130     -
   Bienaime Jean Jacques Director   –       •      –    2023-06-14 4 A $0.00 $0 D/D 2,505 15,493     -
   Harrigan Edmund Director   –       •      –    2023-06-14 4 A $0.00 $0 D/D 2,505 11,500     -

  1564 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 63
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed